NATCO Pharma Limited’s (NATCOPHARM) 20-Day exponential moving average is 1260.12, while NATCO Pharma Limited’s (NATCOPHARM) share price is ₹1,160.55, making it a Sell.

NATCO Pharma Limited’s (NATCOPHARM) 50-Day exponential moving average is 1321.37, while NATCO Pharma Limited’s (NATCOPHARM) share price is ₹1,160.55, making it a Sell.

NATCO Pharma Limited (NATCOPHARM) Pivot Points

Jan 31, 2025, 01:07 PM

Classic

1,039.30

1,074.65

1,111.30

1,146.65

1,183.30

1,218.65

1,255.30

Fibonacci

1,074.65

1,102.15

1,119.15

1,146.65

1,174.15

1,191.15

1,218.65

Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

NATCO Pharma Limited (NATCOPHARM) Moving Averages

Jan 31, 2025, 01:07 PM

MA5

1,211.84Sell

1,195.90Sell

MA10

1,230.83Sell

1,221.95Sell

MA20

1,261.46Sell

1,260.12Sell

MA50

1,350.38Sell

1,321.37Sell

MA100

1,389.65Sell

1,337.41Sell

MA200

1,290.85Sell

1,252.26Sell

NATCO Pharma Limited’s (NATCOPHARM) 10-Day exponential moving average is 1221.95, while NATCO Pharma Limited’s (NATCOPHARM) share price is ₹1,160.55, making it a Sell.

NATCO Pharma Limited’s (NATCOPHARM) 100-Day exponential moving average is 1337.41, while NATCO Pharma Limited’s (NATCOPHARM) share price is ₹1,160.55, making it a Sell.

NATCO Pharma Limited’s (NATCOPHARM) stock price is ₹1,160.55 and NATCO Pharma Limited’s (NATCOPHARM) 50-day simple moving average is 1350.38, creating a Sell signal.

NATCO Pharma Limited’s (NATCOPHARM) stock price is ₹1,160.55 and NATCO Pharma Limited’s (NATCOPHARM) 100-day simple moving average is 1389.65, creating a Sell signal.

NATCO Pharma Limited’s (NATCOPHARM) stock price is ₹1,160.55 and NATCO Pharma Limited’s (NATCOPHARM) 200-day simple moving average is 1290.85, creating a Sell signal.

NATCO Pharma Limited (NATCOPHARM) Technical Indicators

Jan 31, 2025, 01:07 PM

RSI (14)

36.05

Neutral

STOCH (9,6)

18.30

Buy

STOCHRSI (14)

17.90

Buy

MACD (12,26)

-47.49

Buy

ADX (14)

29.04

Neutral

Williams %R

-67.78

Buy

CCI (14)

-136.63

Buy

ATR (14)

46.62

Ultimate Oscillator

42.06

Neutral

ROC

-8.84

Sell

NATCO Pharma Limited’s (NATCOPHARM) Relative Strength Index (RSI) is 36.05, creating a Neutral signal.

NATCO Pharma Limited’s (NATCOPHARM) Trend Strength Indicator (ADX) is 29.04, creating a Neutral signal.

NATCO Pharma Limited’s (NATCOPHARM) Commodity Channel Index (CCI) is -136.63, creating a Buy signal.

NATCO Pharma Limited’s (NATCOPHARM) Price Rate of Change (ROC) is -8.84, creating a Sell signal.

Technical Analysis Screener >

Technical Analysis Screener.

Customize your technical analysis to fit your
unique trading strategy with a flexible screener

Try it Now!

FAQ

Is NATCOPHARM a Buy, Hold, or Sell?

Based on NATCOPHARM’s technical indicators, NATCOPHARM is a Sell.

What is NATCOPHARM’s RSI (14)?

NATCOPHARM’s RSI (14) is 36.05, which suggests NATCOPHARM is a Neutral.

What is NATCOPHARM’s MACD?

NATCOPHARM’s MACD is -47.49, which suggests NATCOPHARM is a Buy.

What is NATCOPHARM’s 5-day moving average?

NATCOPHARM’s 5-day moving average is 1211.84, which suggests NATCOPHARM is a Sell.

What is NATCOPHARM’s 20-day moving average?

NATCOPHARM 20-day moving average is 1261.46, which suggests NATCOPHARM is a Sell.

What is NATCOPHARM’s 50-day moving average?

NATCOPHARM’s 50-day moving average is 1350.38, which suggests NATCOPHARM is a Sell.

What is NATCOPHARM’s 200-day moving average?

NATCOPHARM’s 200-day moving average is 1290.85, which suggests NATCOPHARM is a Sell.

What is NATCOPHARM’s Williams % R (14)?

NATCOPHARM’s Williams % R (14) is -67.78, which suggests NATCOPHARM is a Buy.

What is NATCOPHARM’s CCI (14)?

NATCOPHARM’s CCI (14) is -136.63, which suggests NATCOPHARM is a Buy.

What is the share price of NATCO Pharma Limited?

NATCO Pharma Limited's share price is N/A₹.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing